MDWD

MediWound Ltd

13.39

Nov 03 • 3:59 PM ET -0.11 (-0.81%)

12.75

Aftermarket • 7:30 PM ET -0.64 (-4.78%)

Healthcare Biotechnology Israel Micro NASD

Today, 4:45 PMMediWound announces $15 million firm-commitment bought deal offering of 1.2 million ordinary shares at $12.50 each

Peers: VCEL RCEL MDXG ORGO SMTI SNWV IART SNN ELUT TELA

| Held by: IWM IZRL IWO VTWO IWC IWV VTWG QQQS RSSL VTWV

Scroll to Statements

Index	RUT
Market Cap	172.87M
Enterprise Value	147.07M
Income	-20.18M
Sales	11.86M
Book/sh	2.76
Cash/sh	2.74
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	121
IPO	Mar 20, 2014

P/E	-
Forward P/E	-
PEG	-
P/S	14.58
P/B	4.85
P/C	4.89
P/FCF	-
EV/EBITDA	-
EV/Sales	12.40
Quick Ratio	2.09
Current Ratio	2.32
Debt/Eq	0.27
LT Debt/Eq	0.24
Option/Short	Yes / Yes

EPS (ttm)	-1.60
EPS next Y	-2.20
EPS next Q	-0.71
EPS this Y	-4.37%
EPS next Y	-0.30%
EPS next 5Y	16.86%
EPS past 3/5Y	18.87% 2.36%
Sales past 3/5Y	-13.82% -4.87%
EPS Y/Y TTM	39.18%
Sales Y/Y TTM	-40.26%
EPS Q/Q	53.32%
Sales Q/Q	-45.83%
Earnings	Nov 12 BMO
EPS/Sales Surpr.	-1.09% 19.44%

Insider Own	25.52%
Insider Trans	0.12%
Inst Own	53.86%
Inst Trans	0.17%
ROA	-29.06%
ROE	-72.37%
ROIC	-45.60%
Gross Margin	15.46%
Oper. Margin	-271.59%
Profit Margin	-170.10%
SMA20	6.33%
SMA50	2.45%
SMA200	-11.92%
Trades

Shs Outstand	12.91M
Shs Float	9.62M
Short Float	18.19%
Short Ratio	18.43
Short Interest	1.75M
52W High	19.70 -32.03%
52W Low	11.80 13.47%
Volatility	5.24% 4.33%
ATR (14)	0.54
RSI (14)	55.65
Beta	0.04
Rel Volume	0.95
Avg Volume	94.96K
Volume	89,863

Perf Week	6.69%
Perf Month	-0.89%
Perf Quarter	-5.64%
Perf Half Y	-23.22%
Perf YTD	-27.46%
Perf Year	-26.91%
Perf 3Y	62.90%
Perf 5Y	-48.44%
Perf 10Y	-65.84%
Recom	1.00
Target Price	30.67
Prev Close	13.50
Price	13.39
Change %	-0.81%

Consensus

Strong Buy

Avg. Price Target

$30.67

Implied Upside

+129.1%

Analysts7incl. previous ratings

Rating Distribution7 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jun 02, 2025	Resumed	OOppenheimer	Outperform	$34	+153.9%
May 02, 2025	Initiated	AAlliance Global Partners	Buy	$25	+86.7%
Feb 28, 2025	Initiated	CCraig Hallum	Buy	$39	+191.3%
Jul 16, 2024	Reiterated	MMaxim Group	Buy	$25 → $30	+124.0%
Dec 22, 2022	Initiated	MMaxim Group	Buy	$11	-17.8%
Jul 18, 2022	Resumed	OOppenheimer	Outperform	$7	-47.7%
Sep 23, 2020	Initiated	BBTIG Research	Buy	$6	-55.2%
Nov 28, 2016	Initiated	AAegis Capital	Buy	$11	-17.8%
Aug 17, 2016	Initiated	WWells Fargo	Outperform
Apr 16, 2014	Initiated	OOppenheimer	Outperform	$25	+86.7%

Today 04:40PM	MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares (GlobeNewswire)
08:30AM	MediWound's EscharEx Strategy May Be Ahead of the Game as FDA Puts Chronic Wounds in Focus (Nasdaq: MDWD) (FinanceWire)
Oct-29-26 08:00AM	MediWound to Report Third Quarter 2026 Financial Results (GlobeNewswire)
Sep-22-26 08:09AM	Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) (FinanceWire)
07:00AM	MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid (GlobeNewswire)
07:00AM	Loading…
Sep-14-26 07:00AM	Independent DSMB Recommends MediWound's EscharEx Phase III VALUE Study Continue Without Modification (GlobeNewswire) +5.87%
Sep-02-26 07:00AM	MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference (GlobeNewswire)
Aug-25-26 08:00AM	New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq: MDWD) (FinanceWire)
Aug-13-26 07:07PM	MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ... (GuruFocus.com)
07:11AM	MediWound: Q2 Earnings Snapshot (Associated Press)
07:00AM	MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-29-26 08:00AM	MediWound to Report Second Quarter 2026 Financial Results (GlobeNewswire)
Jul-16-26 08:32AM	Why is Cathie Wood's ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD) (FinanceWire)
Jul-02-26 08:48AM	Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD) (FinanceWire)
May-27-26 05:00PM	MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue ... (GuruFocus.com) -14.09%
07:07AM	Loading…
07:07AM	MediWound: Q1 Earnings Snapshot (Associated Press)
07:00AM	MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update (GlobeNewswire)
May-07-26 08:00AM	MediWound to Report First Quarter 2026 Financial Results (GlobeNewswire)
Apr-13-26 07:30AM	Newly Published U.S. Expert Consensus Aligns with MediWound's Strategy for Chronic Wound Debridement (GlobeNewswire)
Apr-07-26 07:00AM	MediWound to Present New EscharEx Data at Leading Wound Care Conferences (GlobeNewswire)
Apr-02-26 03:26PM	MediWound Reports BARDA Contract Award to Vericel for NexoBrid Valued at up to $197 Million (GlobeNewswire)
Mar-05-26 10:10PM	MediWound Q4 Earnings Call Highlights (MarketBeat)
04:30PM	MediWound Files Annual Report on Form 20-F (GlobeNewswire)
08:20AM	MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:27AM	MediWound: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-28-26 08:05PM	MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference (MarketBeat)
Feb-19-26 08:00AM	MediWound to Report Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-17-26 08:00AM	MediWound to Present at Upcoming Investor Conferences (GlobeNewswire)
Jan-12-26 07:00AM	MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference (GlobeNewswire) -7.86%
07:00AM	Loading…
Dec-10-25 07:00AM	MediWound Reports New Clinical Data Demonstrating NexoBrid's Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries (GlobeNewswire)
Nov-20-25 04:00PM	MediWound Ltd (MDWD) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions ... (GuruFocus.com) -5.60%
08:10AM	MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:10AM	MediWound: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-14-25 05:30PM	IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Nov-13-25 05:30PM	RenovoRx, Inc. (RNXT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-12-25 05:15PM	Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-10-25 06:00PM	FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 05:55PM	Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-05-25 07:30AM	MediWound to Report Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-03-25 08:00AM	MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid (GlobeNewswire)
Sep-30-25 08:45AM	MediWound announces $30M registered direct offering (TipRanks)
Sep-29-25 08:37AM	MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares (GlobeNewswire)
Sep-25-25 07:30AM	MediWound Expands Global Reach with Marketing Approval of NexoBrid in Australia (GlobeNewswire)
Sep-02-25 07:30AM	MediWound's NexoBrid to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress (GlobeNewswire)
Aug-20-25 07:30AM	MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-14-25 08:10AM	MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
07:10AM	MediWound: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-13-25 08:45AM	MediWound Announces New EscharEx Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers (GlobeNewswire)
Aug-07-25 05:30PM	Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-05-25 07:40AM	Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates (Zacks)
Aug-04-25 07:30AM	MediWound to Report Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-24-25 08:50AM	Here's What Could Help MediWound (MDWD) Maintain Its Recent Price Strength (Zacks)
May-22-25 03:03AM	MediWound Ltd (MDWD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Decline (GuruFocus.com)
May-21-25 08:10AM	MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:08AM	MediWound: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
May-20-25 09:21AM	Earnings To Watch: MediWound Ltd (MDWD) Reports Q1 2025 Result (GuruFocus.com)
May-15-25 05:45PM	BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-14-25 08:25PM	OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-13-25 05:40PM	Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +6.81%
07:30AM	MediWound Announces Publication of Phase II EscharEx Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers (GlobeNewswire)
May-12-25 05:15PM	FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.42%
May-08-25 06:05PM	Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-05-25 08:00AM	MediWound to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-28-25 08:00AM	MediWound to Present New EscharEx Data at Leading Wound Care Conferences (GlobeNewswire)
Mar-21-25 06:31PM	MediWound Ltd (MDWD) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Mar-20-25 03:01AM	MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses (GuruFocus.com) -6.73%
Mar-19-25 12:10PM	MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript (SeekingAlpha) -5.14%
08:10AM	MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:17AM	MediWound: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-03-25 08:00AM	MediWound to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-25-25 08:00AM	MediWound Announces Phase III CIDS Publication on NexoBrid for Pediatric Burn Care (GlobeNewswire) -7.28%
Feb-24-25 08:00AM	MediWound to Present at the 45th Annual TD Cowen Health Care Conference (GlobeNewswire)
Feb-13-25 10:27AM	MediWound commences Phase III trial for venous leg ulcers treatment (Clinical Trials Arena)
Feb-12-25 07:00AM	MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx for Treatment of Venous Leg Ulcers (GlobeNewswire)
Feb-04-25 08:00AM	MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-27-25 06:32AM	MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains? (Zacks)
Jan-09-25 08:28AM	Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions (TipRanks)
Dec-17-24 08:00AM	MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025 (GlobeNewswire)
07:27AM	MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Companys Future (TipRanks)
Nov-27-24 02:02AM	MediWound Ltd (MDWD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com)
Nov-26-24 08:15AM	MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:10AM	MediWound: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
Nov-25-24 07:02AM	What To Expect From MediWound Ltd (MDWD) Q3 2024 Earnings (GuruFocus.com) +5.16%
Nov-12-24 08:00AM	MediWound to Report Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-23-24 07:01PM	Rosalind Advisors, Inc. Increases Stake in MediWound Ltd (GuruFocus.com)
Oct-10-24 07:00AM	MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx vs. Collagenase in Patients with Venous Leg Ulcers (GlobeNewswire)
Oct-08-24 08:00AM	MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire)
Sep-03-24 08:00AM	MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) -7.34%
Aug-16-24 10:33AM	MediWound and Vericel win FDA paediatric label expansion for NexoBrid (Medical Device Network) +6.05%
Aug-15-24 04:15PM	MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns (GlobeNewswire)
Aug-14-24 08:15AM	MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:18AM	MediWound: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
Aug-07-24 10:00AM	MediWound (MDWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rubinstein Samuel	Director	Sep 01 '26	Buy	12.62	525	6,626	525	Sep 02 04:02 PM
Rubinstein Samuel	Director	Sep 01 '26	Sale	12.72	525	6,678	0	Sep 02 04:02 PM
Hess Shmuel	COO & Chief Commercial Officer	Aug 27 '26	Sale	12.92	3,958	51,149	0	Aug 28 04:02 PM
Hess Shmuel	COO & Chief Commercial Officer	Aug 26 '26	Sale	13.00	1,865	24,245	0	Aug 28 04:02 PM
Shmulik Hess	Officer	Aug 27 '26	Proposed Sale	12.70	3,958	50,267		Aug 28 06:36 AM
SHAMIR NACHUM	Director	Jun 03 '26	Buy	14.00	6,000	83,996	55,815	Jun 04 04:05 PM
Fox David Morton	Director	Jun 01 '26	Buy	14.11	3,537	49,901	22,283	Jun 02 07:30 AM
Rubinstein Samuel	Director	May 29 '26	Buy	14.33	150	2,150	2,993	Jun 01 07:00 AM
Hess Shmuel	Officer	Dec 02 '25	Proposed Sale	17.21	3,693	63,557		Dec 03 07:44 AM

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

Chief Executive OfficerMr. Ofer Gonen B.Sc.

Chief Financial OfficerMs. Hani Luxenburg

COO & Chief Commercial OfficerDr. Shmulik Hess Ph.D.

Executive VPMr. Yaron Meyer Adv.

Ph.D.Dr. Ety Klinger MBA

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MDWD

MediWound Ltd

Upgrade your Finviz experience